Collegium Pharmaceutical (COLL)
(Real Time Quote from BATS)
$31.50 USD
+0.06 (0.19%)
Updated Jun 5, 2024 11:02 AM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Brokerage Reports
0 items in cart
Collegium Pharmaceutical, Inc. [COLL]
Reports for Purchase
Showing records 41 - 60 ( 91 total )
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Solid 1Q; Despite COVID Impact, Still a Very Profitable Year; Stock Unjustifiably Cheap; Reiterate Buy and $31 Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Solid 4Q; 2020 Earnings Guidance Shows Big Step up in Post-Deal Profitability
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Bringing Nucynta Profits Under One Roof; Raise to $31
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
First time 2020 Guidance: Material Xtampza ER Upside; Raise to $29
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
3Q19: Big Exclusive 2020 Formulary Wins Bolster Confidence in Sustainable Xtampza
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
We are reiterating Collegium as our best idea for 2019 - Buy Recommendation
Provider: G.RESEARCH, LLC
Analyst: KEDRA K
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
2Q19 Results; Solid Quarter; Opioid Litigation Concern Misplaced; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O